All Liver Tests

The Hepatitis B Core Antibody Total Test is a qualitative blood test that detects antibodies to the hepatitis B core antigen (anti-HBc) and reports results as Reactive or Non-Reactive. A reactive result may indicate past or ongoing infection, while a non-reactive result suggests no exposure. This test does not distinguish between IgM and IgG antibodies. Doctors use it to evaluate hepatitis B exposure, confirm infection history, and assess overall immune response.

The Hepatitis B Core Antibody Total Test with Reflex to IgM detects antibodies (anti-HBc) to the hepatitis B core antigen. If the total antibody test is reactive, reflex testing determines if IgM antibodies are present, which indicates recent or acute infection. A reactive total with non-reactive IgM suggests past or chronic infection. Doctors use this test to confirm exposure, distinguish acute from prior infection, and support hepatitis B screening and diagnosis.

The Hepatitis B Immunity Panel Test evaluates immune status by measuring Hepatitis B surface antibody levels in the blood. A positive result typically indicates immunity from vaccination or past infection, while a negative result suggests susceptibility. This test is important for verifying protection, monitoring vaccine response, or determining if additional vaccination or further evaluation for Hepatitis B exposure is needed.

The Hepatitis B Surface Antibody Qualitative Test detects anti-HBs antibodies to the hepatitis B surface antigen and reports results as Reactive or Non-Reactive. A reactive result indicates past exposure, either from hepatitis B infection or prior vaccination, while a non-reactive result suggests no detectable exposure. Doctors use this test to confirm hepatitis B exposure history, evaluate vaccine response, and guide further preventive or diagnostic decisions.

The Hepatitis B Surface Antibody Quantitative Test measures the exact level of anti-HBs antibodies in blood to determine past exposure and whether protective immunity has developed from infection or vaccination. A higher antibody level generally indicates adequate immune response, while a low level suggests limited or no protection. Doctors use this test to confirm vaccine effectiveness, assess immune status, and support hepatitis B screening or preventive care.

The Hepatitis B Surface Antigen (HBsAg) Test with Reflex to Confirmation screens for hepatitis B surface antigen in blood and, if reactive, automatically performs confirmatory testing. A reactive confirmed result indicates an active hepatitis B infection, while a non-reactive result shows no infection. Doctors use this test to diagnose acute or chronic hepatitis B, investigate abnormal liver tests, and guide treatment, monitoring, and infection control decisions.

The Hepatitis B Test (Hepatitis B Surface Antigen with Reflex to Confirmation) screens for hepatitis B surface antigen (HBsAg) in the blood to identify active infection. If the result is positive, a confirmation test is automatically performed to verify accuracy and support proper diagnosis.

The Hepatitis Be Antibody (anti-HBe) Test is a qualitative blood test that detects antibodies to the hepatitis B e antigen and reports results as Reactive or Non-Reactive. A reactive result often indicates lower infectivity and a transition toward recovery or inactive disease, while a non-reactive result suggests no antibodies were detected. Doctors use this test to monitor hepatitis B infection stage, evaluate treatment response, and support long-term disease management.

The Hepatitis Be Antigen (HBeAg) Test is a qualitative blood test that detects the presence of hepatitis B e antigen and reports results as Reactive or Non-Reactive. A reactive result suggests active viral replication and high infectivity, while a non-reactive result indicates no HBeAg detected. Doctors use this test to evaluate hepatitis B disease stage, monitor treatment effectiveness, and assess risk of transmission, supporting long-term infection management.

The Hepatitis Be Panel evaluates markers of hepatitis B viral replication and infectivity by measuring hepatitis Be antigen (HBeAg) and antibody (anti-HBe). The presence of HBeAg indicates active viral replication and higher infectivity, while anti-HBe suggests reduced viral activity and improved immune control. This test aids in assessing disease stage, monitoring therapy, and guiding prognosis in hepatitis B infection.

The Hepatitis C Antibody with HCV RNA Quantitative PCR test is a comprehensive diagnostic test used to detect and confirm the presence of the Hepatitis C virus (HCV) in the blood. It combines the initial screening for HCV antibodies with a quantitative polymerase chain reaction (PCR) test to measure the viral load.

 The Hepatitis C Antibody & Liver Function Panel is a comprehensive diagnostic tool used to detect the presence of hepatitis C virus (HCV) antibodies and assess liver function. This panel includes the Hepatitis C Antibody with Reflex to Quantitative HCV RNA PCR test, along with a series of liver function tests: Albumin, Albumin/Globulin Ratio, Alkaline Phosphatase, Alanine Transaminase (ALT), Aspartate Aminotransferase (AST), Bilirubin Direct, Bilirubin Indirect, Bilirubin Total, Globulin, and Protein Total. This panel is crucial for diagnosing HCV infection and evaluating the liver's health and functionality.

The Hepatitis C Viral RNA Genotype Lipa Test analyzes RNA to determine the genotype of the hepatitis C virus. Genotyping is essential because HCV strains vary in treatment response and prognosis. This test provides key insights into viral behavior, supports treatment planning, and aids in monitoring patients with chronic hepatitis C, helping guide decisions that impact long-term liver health outcomes.

The Hepatitis C Viral RNA Quantitative Test measures the amount of hepatitis C virus (HCV) RNA in blood to determine viral load. This test confirms active infection, evaluates disease severity, and monitors response to antiviral therapy. High viral load indicates significant viral replication, while lower or undetectable levels suggest effective treatment or controlled infection. Doctors use this test to guide therapy, track progress, and manage long-term liver health.

The Acute Hepatitis Panel with Reflex to Confirmation detects recent or acute infection by hepatitis A (IgM), B (surface antigen, core IgM), and C (antibody with reflex to RNA PCR) using immunoassay. Reflex confirmation ensures accurate diagnosis for hepatitis B surface antigen positives and reactive HCV antibodies. Use is indicated for symptomatic patients with jaundice, dark urine, fatigue, abdominal pain, or elevated liver enzymes.

The General Hepatitis Panel Test screens for multiple hepatitis infections in one order. It includes Hepatitis A Antibody Total, Hepatitis B Surface Antibody Qualitative, Hepatitis B Surface Antigen with Reflex to Confirmation, Hepatitis B Core Antibody Total, and Hepatitis C Antibody with Reflex to RNA PCR. Doctors use this panel to detect past exposure, confirm active or chronic infection, guide treatment, and support liver health monitoring.

The Herpes Virus 6 IgG IgM Antibodies Test detects immune response to HHV-6, a virus linked to roseola and other illnesses. IgM antibodies suggest recent or acute infection, while IgG indicates past exposure or reactivation. This test supports evaluation of fever, rash, or neurologic symptoms and may help identify complications in immunocompromised patients, providing valuable insight into HHV-6 infection status and immune activity.

The HLA DRB1 DQB1 Low Resolution Test determines genetic variations within the HLA class II region, specifically DRB1 and DQB1 alleles. These markers play an important role in immune system regulation and are associated with autoimmune conditions such as type 1 diabetes, celiac disease, and rheumatoid arthritis. This test provides insight into genetic predisposition, transplant matching, and immune-related disease risk.

The HLA-B27 Antigen Test detects the presence of the HLA-B27 protein on white blood cells, which is linked to autoimmune conditions. A positive result may indicate higher risk for ankylosing spondylitis, reactive arthritis, or other spondyloarthropathies. Doctors order this test to investigate chronic back pain, joint inflammation, or autoimmune family history. Results provide critical insight into genetic predisposition, immune system activity, and inflammatory disease risk.

The Immunoglobulin A (IgA) Test measures IgA antibody levels in blood to evaluate immune system health and mucosal defense in the respiratory and digestive tracts. Low IgA may indicate immune deficiency, celiac disease, or recurrent infections, while high levels may suggest autoimmune disorders, liver disease, or chronic inflammation. Doctors use this test to assess unexplained illness or immune imbalance. Results provide key insight into antibody function and overall immunity.

The Iron Total and Total Iron Binding Capacity (TIBC) Test measures iron levels in blood along with the blood’s ability to transport iron. It helps diagnose iron deficiency anemia, iron overload (hemochromatosis), and monitor nutritional or chronic health conditions. Low iron or high TIBC may indicate anemia, while high iron or low TIBC can suggest overload. Doctors use this test to evaluate fatigue, weakness, or other symptoms linked to iron and metabolic health.

The Iron Micronutrient Test measures blood iron levels to evaluate nutritional status and detect deficiencies or excess. Iron is essential for hemoglobin production, oxygen transport, energy metabolism, and immune function. This test helps identify anemia, iron overload, absorption issues, or dietary imbalances, supporting diagnosis and management of overall health and vital body functions.

Patient must be 18 years of age or older.

The Iron Total Test measures iron levels in blood to evaluate nutritional status, red blood cell production, and overall metabolic health. Abnormal levels may indicate iron deficiency anemia, chronic blood loss, or poor absorption, while high levels may suggest hemochromatosis, liver disease, or iron overload. Doctors use this test to investigate fatigue, weakness, or pallor and to monitor treatment. Results provide key insight into anemia and iron balance.